SciMedBE
ActiveSummary
SciMedBE has been active since 2016 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show negative equity (-€441,284) and a net result of €6,606. Equity is shrinking by about 25% per year across the filed financial years. Its solvency ranks better than 9% of 613 sector peers (NACE 72, financial year 2025). The computed 12-month bankruptcy probability is 0.7% (low).
History
Acts, filings and financial milestones
Next filing, financial year 2026, expected by
2026
30-07
NBB filing
Annual accounts filed
financial year 2025 · micro format
2025
24-07
NBB filing
Annual accounts filed
financial year 2024 · micro format
2024
31-12
Financial
Back to profitnet €32,448
Net result €32,448 after 5 loss-making years.
30-07
NBB filing
Annual accounts filed
financial year 2023 · micro format
2023
26-07
NBB filing
Annual accounts filed
financial year 2022 · micro format
2022
31-12
Financial
Weakest financial yearnet -€154,733
Net result drops to -€154,733, the lowest in the series; recovery starts the following year.
26-07
NBB filing
Annual accounts filed
financial year 2021 · micro format
2021
30-07
NBB filing
Annual accounts filed
financial year 2020 · micro format
2020
29-07
NBB filing
Annual accounts filed
financial year 2019 · micro format
2019
26-06
NBB filing
Annual accounts filed
financial year 2018 · micro format
2018
26-06
NBB filing
Annual accounts filed
financial year 2017 · micro format
Financial milestoneNBB filingFinancial milestones sit on the financial year-end date, not the filing date.
0 of 3 deeds read
About the unread acts
We know of 3 Belgian Official Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.
Have them read with priority
Sign in to place this company at the front of the reading queue.